UnitedHealth Earnings Beat, Revenue Outlook Soft

UnitedHealth earnings beat fourth-quarter estimates but warned revenue will decline, a split result that could shift near-term trader positioning.

January 27, 2026·1 min read
View all news articles
Flat vector of a health insurer vault with a dimming light to symbolize UnitedHealth earnings and a softer revenue outlook.

KEY TAKEAWAYS

  • UnitedHealth beat fourth-quarter estimates despite a $1.6 billion restructuring charge that cut profit to $10 million.
  • Consolidated 2025 revenue totaled $447.6 billion, up 12.0% year-over-year.
  • Guidance calls for revenue decline while adjusted profit is expected slightly above estimates; Medicare Advantage growth 5.1%.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

UnitedHealth Group (UNH) reported fourth-quarter earnings that exceeded analyst expectations, the company said in a Jan. 27 press release, but forecast a decline in 2026 revenue as Medicare Advantage pressures persist. Cost controls under CEO Stephen Hemsley are expected to keep adjusted profit slightly above estimates.

Fourth-Quarter Results and Charges

UnitedHealth reported consolidated 2025 revenue of $447.6 billion, a 12% increase from the prior year. The company recorded a $1.6 billion restructuring charge in the fourth quarter related to its financial turnaround, which reduced quarterly profit to $10 million.

The quarter modestly beat analyst consensus, which had projected earnings per share between $2.10 and $2.12 and revenue near $113.6 billion to $113.8 billion.

2026 Outlook and Medicare Advantage Rates

UnitedHealth’s guidance projects a decline in 2026 revenue, citing finalized Medicare Advantage payment growth of 5.06% for the year. The Trump administration described the rate as disappointing, a factor the company said weighed on its top line.

The company expects adjusted 2026 profit to come in slightly above analyst estimates, supported by medical cost controls overseen by Hemsley. UnitedHealth said a stronger finish to 2025 provided momentum for its turnaround efforts.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Anta Buys Puma Stake for $1.8 Billion

Anta Buys Puma Stake for $1.8 Billion

Anta buys Puma stake, paying about $1.8 billion for 29.06%, financed with internal cash and targeting close by end-2026, shifting ownership and China trade

EU-India Trade Deal Cuts Tariffs on Key Goods

EU-India Trade Deal Cuts Tariffs on Key Goods

EU-India Trade Deal cuts duties across machinery, autos and food, projects export growth and reshapes trade flows ahead of early 2027 ratification.

GM Q4 Earnings Preview After EV Write-Downs

GM Q4 Earnings Preview After EV Write-Downs

GM Q4 earnings will test whether a $6.0B EV write-down and idling of two Ultium Cells plants reshape trading, cash flow and EPS expectations.

Nike Layoffs Accelerate Distribution Automation

Nike Layoffs Accelerate Distribution Automation

Nike layoffs consolidate U.S. distribution and speed supply chain automation, tightening the cost outlook and shifting expectations for EBIT-margin recovery.

Treasury Cancels Booz Allen Contracts After Tax-Return Leak

Treasury Cancels Booz Allen Contracts After Tax-Return Leak

Treasury cancels Booz Allen contracts after an IRS tax-data leak, removing federal spending and creating a near-term revenue and obligations gap.

Leidos Acquires ENTRUST for $2.4 Billion

Leidos Acquires ENTRUST for $2.4 Billion

Leidos acquires ENTRUST, doubling its energy unit; the all-cash $2.4 billion deal raises financing and integration risk and may sway trader positioning.